Cover Image
Market Research Report

LAMEA Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 941733
Published Content info 104 Pages
Delivery time: 1-2 business days
Price
Back to Top
LAMEA Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026
Published: May 31, 2020 Content info: 104 Pages
Description

Title:
LAMEA Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026.

The Latin America, Middle East and Africa Clinical Nutrition Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026).

Dietary therapy is critical to proper growth and development, the prevention of acute complications, and/or the prevention of long-term complications of a given disorder. Failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for people with hereditary metabolic disorders is life-long. The treatment of patients with multiple inborn metabolism mistakes includes a multidisciplinary strategy that incorporates diet and medical care.

Brazil's market dominated the region of Latin America due to an increase in the obese population and an increase in the incidence of chronic diseases. The high incidence of preterm births, contributing to a rise in demand for clinical nutrition, would benefit Brazil's market growth. In addition, a strong association with the American Society of Parenteral and Enteral Nutrition is helping to grow the country's clinical nutrition market.

The presence of associations such as the South African Society for Enteral and Parental Nutrition, creating awareness of clinical nutrition in the country, coupled with the increasing burden of disease, will drive the South African market over the forecast timeframe. Health infrastructure creation and growing efforts from both the public and private sectors to improve sales of dietary formulas throughout the country would fuel market growth.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration

  • Oral
  • Enteral and
  • Parenteral

By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Clinical Nutrition Market, by Route of Administration
    • 1.4.2 LAMEA Clinical Nutrition Market, by Application
    • 1.4.3 LAMEA Clinical Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players

Chapter 4. LAMEA Clinical Nutrition Market by Route Of Administration

  • 4.1 LAMEA Oral Market by Country
  • 4.2 LAMEA Enteral Market by Country
  • 4.3 LAMEA Parenteral Market by Country

Chapter 5. LAMEA Clinical Nutrition Market by Application

  • 5.1 LAMEA Cancer Market by Country
  • 5.2 LAMEA Neurological Diseases Market by Country
      • 5.2.1.1 LAMEA Gastrointestinal Disorders Market by Country
  • 5.3 LAMEA Metabolic Disorders Market by Country
  • 5.4 LAMEA Other Applications Market by Country

Chapter 6. LAMEA Clinical Nutrition Market by End User

  • 6.1 LAMEA Adults Clinical Nutrition Market by Country
  • 6.2 LAMEA Pediatric Market by Country
  • 6.3 LAMEA Geriatric Market by Country

Chapter 7. LAMEA Clinical Nutrition Market by Country

  • 7.1 Brazil Clinical Nutrition Market
    • 7.1.1 Brazil Clinical Nutrition Market by Route Of Administration
    • 7.1.2 Brazil Clinical Nutrition Market by Application
    • 7.1.3 Brazil Clinical Nutrition Market by End User
  • 7.2 Argentina Clinical Nutrition Market
    • 7.2.1 Argentina Clinical Nutrition Market by Route Of Administration
    • 7.2.2 Argentina Clinical Nutrition Market by Application
    • 7.2.3 Argentina Clinical Nutrition Market by End User
  • 7.3 UAE Clinical Nutrition Market
    • 7.3.1 UAE Clinical Nutrition Market by Route Of Administration
    • 7.3.2 UAE Clinical Nutrition Market by Application
    • 7.3.3 UAE Clinical Nutrition Market by End User
  • 7.4 Saudi Arabia Clinical Nutrition Market
    • 7.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
    • 7.4.2 Saudi Arabia Clinical Nutrition Market by Application
    • 7.4.3 Saudi Arabia Clinical Nutrition Market by End User
  • 7.5 South Africa Clinical Nutrition Market
    • 7.5.1 South Africa Clinical Nutrition Market by Route Of Administration
    • 7.5.2 South Africa Clinical Nutrition Market by Application
    • 7.5.3 South Africa Clinical Nutrition Market by End User
  • 7.6 Nigeria Clinical Nutrition Market
    • 7.6.1 Nigeria Clinical Nutrition Market by Route Of Administration
    • 7.6.2 Nigeria Clinical Nutrition Market by Application
    • 7.6.3 Nigeria Clinical Nutrition Market by End User
  • 7.7 Rest of LAMEA Clinical Nutrition Market
    • 7.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
    • 7.7.2 Rest of LAMEA Clinical Nutrition Market by Application
    • 7.7.3 Rest of LAMEA Clinical Nutrition Market by End User

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 B. Braun Melsungen AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Partnerships, Collaborations, and Agreements:
  • 8.3 Baxter International, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Segmental and Regional Analysis
    • 8.4.3 Research & Development Expense
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
  • 8.5 Nestle S.A.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research& Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
      • 8.5.5.3 Geographical Expansions:
  • 8.6 Lonza Group AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Acquisition and Mergers:
  • 8.7 BASF SE
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8 Ajinomoto Co., Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental & Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
  • 8.9 Perrigo Company PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.1 Hero Nutritionals, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- CLINICAL NUTRITION MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- CLINICAL NUTRITION MARKET
  • TABLE 5 MERGERS & ACQUISITIONS - CLINICAL NUTRITION MARKET
  • TABLE 6 GEOGRAPHICAL EXPANSIONS - CLINICAL NUTRITION MARKET
  • TABLE 7 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 8 LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 9 LAMEA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 LAMEA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 LAMEA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 LAMEA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 LAMEA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 14 LAMEA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 15 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 16 LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 17 LAMEA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 LAMEA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 24 LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 25 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 28 LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 29 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 LAMEA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 32 LAMEA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 33 LAMEA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 LAMEA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 BRAZIL CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 38 BRAZIL CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 39 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 40 BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 41 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 42 BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 43 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 44 BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 45 ARGENTINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 46 ARGENTINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 47 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 48 ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 49 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 50 ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 51 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 52 ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 53 UAE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 UAE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 56 UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 57 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 58 UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 59 UAE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 60 UAE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 61 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 62 SAUDI ARABIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 63 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 64 SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 65 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 66 SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 67 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 68 SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 69 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 70 SOUTH AFRICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 71 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 72 SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 73 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 74 SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 75 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 76 SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 77 NIGERIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 78 NIGERIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 79 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 80 NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 81 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 82 NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 83 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 84 NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 85 REST OF LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 86 REST OF LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 87 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 88 REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 89 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 90 REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 91 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 92 REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 93 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 94 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 95 KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 96 KEY INFORMATION - PFIZER, INC.
  • TABLE 97 KEY INFORMATION - NESTLE S.A.
  • TABLE 98 KEY INFORMATION - LONZA GROUP AG
  • TABLE 99 KEY INFORMATION - BASF SE
  • TABLE 100 KEY INFORMATION -AJINOMOTO CO., INC.
  • TABLE 101 KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 102 KEY INFORMATION - HERO NUTRITIONALS, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, JAN - 2019, DEC) LEADING PLAYERS
  • FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2016, MAR - 2019, OCT) LEADING PLAYERS
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
  • FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
  • FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
Back to Top